EXPI eXp Realty International Corp

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Upending the Marketing Playbook So, you're telling me there's a new sheriff in town when it comes to audience discovery and media planning? Well, slap my knees and call me impressed, because Causal just launched something they call Causal ONE. Apparently, this is the new whiz-bang platform designed to drag marketers into the future by the scruff of their necks. This thing...

An Investor's Battle with Bank of America Bank of America Corporation, or as Wall Street folks call it, BAC, is under the microscope thanks to a securities fraud lawsuit that’s beginning to stir the pot. This lawsuit has caught the attention of the litigators at Schall, Brown & Schwartz LLP, who are sharp enough to smell opportunity where the rest of us sense chaos....

Bluetooth HDT: The Next Leap in Connectivity Ceva's been in the game long before the rules were even set. With the introduction of Bluetooth High Data Throughput (HDT), they're not just playing; they're innovating. This tech doesn't just boost connectivity—it multiplies it, enhancing Bluetooth's reliability and energy efficiency while quadrupling data throughput. That's...

Seat belts on, folks! Adient's latest earnings reveal a tale of two narratives: hefty cash flow on one side and tricky losses on the other. As the automotive seating juggernaut details its fiscal roadmap, there's lots for investors to chew on. Financial Recap: Q4 Ups and Downs Jumping right in, Adient's fourth-quarter pop wasn't champagne-worthy, but there are whispers of...

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Here's a Shift: Reliability Over Specs Alright, folks, buckle up because Ampace is shaking things up at EICMA Milan this year. While some are still yammering on about juicing up specs, Ampace is talking reliability. It's a bold move in the fast-evolving two-wheeler battery market, where everyone's been obsessed with horsepower and max speeds. The landscape's shifting...

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Deadline Looms Large for AST SpaceMobile Investors Hot topic off the wire, folks: AST SpaceMobile's in hot water with a securities fraud class action lawsuit breathing down its neck. You got till November 13 to file for lead plaintiff status. If you picked up shares of NASDAQ:ASTS during the period from March 4, 2025, to July 15, 2026, now might just be the time to sit up...

ROMTech Aims High with Website Revamp ROM Technologies, Inc., the medtech trailblazer, is taking a bold step by launching a fresh, spiffy corporate website. This overhaul isn't just about fancy graphics or slick user interfaces—though those are here in droves. We're talking a genuine commitment here to enhancing post-discharge recovery through home-based tech solutions....

Bluerock High Income Fund Announces Latest Financial Updates Bluerock High Income Institutional Credit Fund, a notable player in the investment landscape, has recently revealed its quarterly distribution figures. Currently, the Fund is set to distribute approximately $0.52 per share, which translates to a remarkable 9.0% annualized distribution rate. This latest...

Airlink Inc. Welcomes New Leadership for 2025-2027 Airlink, Inc. is excited to introduce its new Board of Trustees members for the upcoming term, bringing a wealth of experience across diverse fields crucial to the aviation sector. This year's board welcomes six new members whose backgrounds span law, engineering, technology, and international relations, perfect for...

MindHYVE.ai™ Demonstrates ChironAI™ at Leading CME Event MindHYVE.ai™ recently made an impactful appearance at a prestigious Continuing Medical Education (CME) session focused on innovations in cardiovascular imaging. The event gathered a variety of healthcare professionals including senior cardiologists, radiologists, and imaging specialists from various regions,...

UBS Adjusts Price Target for McDonald's Stock McDonald's Corporation (NYSE: MCD) has recently captured the attention of investors, as UBS has raised its price target on the fast-food giant's stock from $305 to an impressive $345. This revision is buoyed by strong sales growth potential that the company is expected to experience through the end of 2024 and into 2025. With...

Understanding the Kroger-Albertsons Merger Situation The legal proceedings surrounding the merger between Kroger and Albertsons have the potential to reshape the grocery industry considerably. This courtroom battle is crucial, as it involves the largest supermarket merger proposal in U.S. history, raising numerous concerns from both consumers and investors. Initially...